Grant: Doctoral: Vanier Canada Graduate Scholarships
University of British Columbia
$100,000.00
Exploring the development of endotoxin tolerance in sepsis.
EF 2009-10
Résumé
The innate immune response is the first line of defense against microorganisms. However, if this response is highly stimulated, it can result in excessive inflammation that can lead to organ injury and high mortality. Sepsis, often caused by bacterial infection in the bloodstream, is an example of the consequences of uncontrolled inflammation. In the United States, sepsis is the leading cause of death in critically ill patients with more than 200,000 fatalities annually. Sepsis can be initiated by bacteria or bacterial products such as lipopolysaccharide (LPS). Initially, septic patients exhibit a pronounced and vigorous innate immune response, but eventually, this shifts towards an immunosuppressive state. This state is related with a phenomenon called endotoxin tolerance, which is basically the reduced or null capacity of the immune cells to respond to bacterial products, after they have been in previous contact with these products. The purpose of endotoxin tolerance may be to reduce the immune response and lessen the consequences of excessive inflammation, although this may also increase the risk of subsequent infections and death. Therefore, the main aim of this project is to explore the development of endotoxin tolerance during sepsis, and to analyze how this may increase fatality. Studying cells from patients with human sepsis during the different stages of the syndrome, will allow me to see changes in the immune response, and to find possible markers of endotoxin tolerance that can be correlated with mortality. In the long term, the potential blockage of these markers in septic patients undergoing an endotoxin tolerance stage, could lead to improvements in their clinical outcome.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
197323
Name
Pena Olga M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Exploring the development of endotoxin tolerance in sepsis.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Immunosupression; Infectious Diseases; Inflammation; Sepsis
Abstract
The innate immune response is the first line of defense against microorganisms. However, if this response is highly stimulated, it can result in excessive inflammation that can lead to organ injury and high mortality. Sepsis, often caused by bacterial infection in the bloodstream, is an example of the consequences of uncontrolled inflammation. In the United States, sepsis is the leading cause of death in critically ill patients with more than 200,000 fatalities annually. Sepsis can be initiated by bacteria or bacterial products such as lipopolysaccharide (LPS). Initially, septic patients exhibit a pronounced and vigorous innate immune response, but eventually, this shifts towards an immunosuppressive state. This state is related with a phenomenon called endotoxin tolerance, which is basically the reduced or null capacity of the immune cells to respond to bacterial products, after they have been in previous contact with these products. The purpose of endotoxin tolerance may be to reduce the immune response and lessen the consequences of excessive inflammation, although this may also increase the risk of subsequent infections and death. Therefore, the main aim of this project is to explore the development of endotoxin tolerance during sepsis, and to analyze how this may increase fatality. Studying cells from patients with human sepsis during the different stages of the syndrome, will allow me to see changes in the immune response, and to find possible markers of endotoxin tolerance that can be correlated with mortality. In the long term, the potential blockage of these markers in septic patients undergoing an endotoxin tolerance stage, could lead to improvements in their clinical outcome.
Competitiondate
200911
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Pena, Olga M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~